Article

Opioids: Nonmedical Use and Abuse in Older Children

Department of Pediatrics, Medical College of Wisconsin and Children's Research Institute, Milwaukee, WI, USA.
Pediatrics in Review (Impact Factor: 0.82). 04/2011; 32(4):e44-52. DOI: 10.1542/pir.32-4-e44
Source: PubMed

ABSTRACT

• Prescription opioids constitute most nonmedical opioid use and abuse in older children, and medical opioid use places pediatric users at increased risk for nonmedical use. • Prevalence data demonstrate that pediatric nonmedical use increases over a person's lifetime, necessitating regular, ongoing prevention and screening measures. • Pain control is the most common reason for nonmedical opioid use. • Research data indicate friends and families are the most common sources for opioid diversion, with recent medical opioid users being at higher risk to divert opioids. • Strong evidence correlates nonmedical opioid use with increased substance abuse, with a significant minority of users experiencing both opioid abuse and dependence. • Central respiratory depression/apnea, severely depressed consciousness/coma, and pinpoint pupils are signs of opioid overdose. • Pediatricians should incorporate prevention strategies into their anticipatory guidance and prescribing practices. • Pediatricians must screen for nonmedical opioid use and associated substance abuse using a combination of clinical questioning and screening tools. • Primary opioid overdose management includes appropriate airway and ventilation management, circulation support, and administration of an opioid antagonist.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The American Society for Pain Management Nursing (ASPMN) has updated its position statement on managing pain in patients with substance use disorders. This position statement is endorsed by the International Nurses Society on Addictions (IntNSA) and includes clinical practice recommendations based on current evidence. It is the position of ASPMN and IntNSA that every patient with pain, including those with substance use disorders, has the right to be treated with dignity, respect, and high-quality pain assessment and management. Failure to identify and treat the concurrent conditions of pain and substance use disorders will compromise the ability to treat either condition effectively. Barriers to caring for these patients include stigmatization, misconceptions, and limited access to providers skilled in these two categories of disorders. Topics addressed in this position statement include the scope of substance use and related disorders, conceptual models of addiction, ethical considerations, addiction risk stratification, and clinical recommendations.
    No preview · Article · Sep 2012 · Pain management nursing: official journal of the American Society of Pain Management Nurses
  • [Show abstract] [Hide abstract]
    ABSTRACT: The American Society for Pain Management Nursing (ASPMN) has updated its position statement on managing pain in patients with substance use disorders. This position statement is endorsed by the International Nurses Society on Addictions (IntNSA) and includes clinical practice recommendations based on current evidence. It is the position of ASPMN and IntNSA that every patient with pain, including those with substance use disorders, has the right to be treated with dignity, respect, and high-quality pain assessment and management. Failure to identify and treat the concurrent conditions of pain and substance use disorders will compromise the ability to treat either condition effectively. Barriers to caring for these patients include stigmatization, misconceptions, and limited access to providers skilled in these two categories of disorders. Topics addressed in this position statement include the scope of substance use and related disorders, conceptual models of addiction, ethical considerations, addiction risk stratification, and clinical recommendations.
    No preview · Article · Oct 2012 · Journal of Addictions Nursing
  • [Show abstract] [Hide abstract]
    ABSTRACT: RATIONALE: The use and misuse of prescription opiates in adolescent populations, and in particular, adolescent female populations, has increased dramatically in the past two decades. Given the significant role that opioids play in neuroendocrine function, exposure to opiates during this critical developmental period could have significant consequences for the female, as well as her offspring. OBJECTIVES: In the current set of studies, we utilized the female rat to model the transgenerational impact of adolescent opiate exposure. METHODS: We examined locomotor sensitization in response to the dopamine D2/D3 receptor agonist quinpirole in the adult male progeny (F1 and F2 generations) of females exposed to morphine during adolescence. All females were drug-free for at least 3 weeks prior to conception, eliminating the possibility of direct fetal exposure to morphine. RESULTS: Both F1 and F2 progeny of morphine-exposed females demonstrated attenuated locomotor sensitization following repeated quinpirole administration. These behavioral effects were coupled with increased quinpirole-induced corticosterone secretion and upregulated kappa opioid receptor and dopamine D2 receptor (D2R) gene expression within the nucleus accumbens. CONCLUSIONS: These results suggest significant modifications in response to repeated D2R activation in the progeny of females exposed to opiates during adolescence. Given the significant role that the D2R plays in psychopathology, adolescent opiate exposure could shift the vulnerability of future offspring to psychological disorders, including addiction. Moreover, that effects are also observed in the F2 generation suggests that adolescent opiate exposure can trigger transgenerational epigenetic modifications impacting systems critical for motivated behavior.
    No preview · Article · Jan 2013 · Psychopharmacology